Gayathri Vijayakumar, PhD

Gayathri Vijayakumar, PhD has a diverse work experience in the field of biology and biotechnology. Gayathri is currently working at Scribe Therapeutics as a Senior Scientist II in Delivery Platform Engineering. In this role, they are responsible for devising strategies and executing screening campaigns for creating novel CRISPR-Cas virally inspired delivery systems.

Prior to their current role, Gayathri worked as a Senior Scientist I at Scribe Therapeutics, where they continued their work in Delivery Platform Engineering. Gayathri also served as a Scientist I in the same department, where they played a key role in devising strategies and executing screening campaigns for viral genetically encoded elements.

Before joining Scribe Therapeutics, Gayathri was a PhD Student at the Icahn School of Medicine at Mount Sinai. During their time there, they worked under the guidance of Dr. Peter Palese in the Department of Microbiology. Gayathri led a collaboration with a Pharma partner and MSKCC on a pre-clinical oncolytic immunotherapy candidate that successfully transitioned into Phase 1/1b clinical trial.

Gayathri also has experience as a Senior Research Associate at Weill Cornell Medicine, where they investigated Wnt/β-catenin signaling as an early, HER2/neu-inducible event in breast neoplasia. Gayathri conducted analysis and compared expression patterns in mouse mammary glands using various techniques.

Gayathri started their professional career as a Graduate Assistant at New York University, where they investigated electromagnetic pulse signals in stimulating bone formation for an orthopedic company. Additionally, they have interned at Tuberculosis Research Centre, Rajiv Gandhi Center for Biotechnology, J&J Biotech and Specialty Chemicals (Pvt.) Ltd., and A.V.Thomas Group Companies, L.J. International Ltd., gaining valuable experience in various research and intern roles.

Overall, Gayathri Vijayakumar, PhD has a strong background in biology and biotechnology, with expertise in CRISPR-Cas delivery systems, oncolytic immunotherapy, Wnt/β-catenin signaling, and bone formation research. Gayathri'sdiverse work experience demonstrates their ability to work in different research settings and contribute to the advancement of scientific knowledge.

Gayathri Vijayakumar, PhD, has a diverse education history in the field of biotechnology and microbiology. Gayathri completed their Doctor of Philosophy (PhD) in Microbiology and Immunology at the Icahn School of Medicine at Mount Sinai. Prior to that, Gayathri obtained their Master of Science (MS) degree in Biotechnology from NYU Tandon School of Engineering. Gayathri also holds a Bachelor's degree in Tech Biotechnology from Sathyabama University. In addition to their formal education, Gayathri has obtained certifications, including a Management Training Program from OneDigital in April 2022 and BSL3 Training from the CITI Program in October 2016.